Truist downgrades Pacira BioSciences to Hold, sets $36.50 target
Truist Securities downgraded Pacira BioSciences to Hold and set a $36.50 price target, roughly in line with the Oct 8 close of $36.39.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.